LOGIN  |  REGISTER
Astria Therapeutics
C4 Therapeutics

Merit Medical Systems Shareholders Elect Silvia M. Perez as New Director

May 16, 2024 | Last Trade: US$97.13 1.87 -1.89

SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and Transportation Division at 3M Company, as a director in Merit’s Annual Meeting of Shareholders held on May 15, 2024. Merit’s shareholders also re-elected Fred P. Lampropoulos and Stephen C. Evans as directors. Ms. Perez and Messrs. Lampropoulos and Evans were elected to serve three-year terms.

"We are pleased to welcome Silvia Perez as our newest director,” said Mr. Lampropoulos, Merit’s Chairman and Chief Executive Officer. “Her expertise and proven track record of leadership success will provide valuable industry and organizational perspective to both the board and the company’s management team as we pursue our continued growth initiatives.”

“I'm honored to join the Merit Board of Directors,” Perez said. “I believe in the company's mission to improve and save lives around the globe. I'm excited to bring my experience to the team as they propel this mission forward." 

Ms. Perez has worked for more than two decades in the healthcare industry, with accomplishments in clinical, regulatory, operations, marketing, and business leadership. 

She joined 3M Company in 1994 and has held a variety of leadership roles across the organization, both domestic and international. Roles include President of Commercial Solutions Division and Vice President of Acelity, Inc., which was the largest acquisition in the history of 3M Company.

Ms. Perez holds a pharmaceutical chemist degree from the University of the Republic (Uruguay), and is an industrial pharmacist educated at the Federal University of Parana (Brazil). She holds Six Sigma Black Belt and Master Black Belt certifications.

ABOUT MERIT MEDICAL

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,000 people worldwide. 

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.  

CONTACTS 
PR/Media Inquiries 
Sarah Comstock 
Merit Medical 
+1-801-432-2864 | This email address is being protected from spambots. You need JavaScript enabled to view it. 

INVESTOR INQUIRIES 
Mike Piccinino, CFA, IRC 
Westwicke - ICR 
+1-443-213-0509 | This email address is being protected from spambots. You need JavaScript enabled to view it.

C4 Therapeutics

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB